October 30, 2026

Savara, Inc. (SVRA) Stock Analysis: An Unveiling of Its 123% Potential Upside

Savara, Inc. (SVRA), a pivotal player in the biopharmaceutical landscape, is drawing significant investor attention with a potential upside that could redefine its market positioning. With..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating Investment Terrain with a 20.15 Forward P/E

Fortrea Holdings Inc. (NASDAQ: FTRE) is making a name for itself in the healthcare sector, specifically within the biotechnology industry. This contract research organization, based in..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating a 44.53% Potential Upside in the Healthcare Sector

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector under the medical care facilities industry, is capturing investor attention with a notable potential..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 307% Potential Upside in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company headquartered in San Diego, California, is drawing significant investor attention with its ambitious pipeline and substantial projected..

Simulations Plus, Inc. (SLP) Stock Analysis: A Steady Player in Health Information Services with 7.5% Revenue Growth

Simulations Plus, Inc. (NASDAQ: SLP) stands as a unique entity in the healthcare sector, specializing in health information services. Headquartered in the United States, Simulations Plus..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 105% Potential Upside in Biotech Innovation

Precigen, Inc. (NASDAQ: PGEN), a pioneering biopharmaceutical firm, stands out with its remarkable 105.57% potential upside, intriguing investors eager to capitalize on the biotech sector’s growth...

LifeMD, Inc. (LFMD) Stock Analysis: Eyeing a 250% Potential Upside Amid Strong Buy Ratings

LifeMD, Inc. (LFMD), a trailblazer in the burgeoning telehealth sector, is catching the attention of investors with a compelling potential upside of 250.22%. Despite facing challenges,..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a Potential 29.87% Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, offers investors a unique opportunity to tap into the burgeoning market of senior care..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a Promising 16.32% Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN) stands out as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.96..

Butterfly Network, Inc. (BFLY) Stock Analysis: Investors Eye 48.69% Potential Upside

In the rapidly evolving healthcare sector, Butterfly Network, Inc. (NASDAQ: BFLY) is making waves with its cutting-edge medical devices, capturing the attention of investors looking for..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Xencor, Inc. (XNCR) Stock Analysis: Navigating a 42% Upside Potential with Strong Buy Ratings

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, has been capturing the interest of investors with its robust pipeline focused on engineered antibodies for cancer and..

Evolus, Inc. (EOLS) Stock Analysis: Strong Analyst Ratings and Almost 100% Upside Potential

Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, is catching investor attention with..

Oculis Holding AG (OCS) Stock Analysis: A 351% Potential Upside in the Biotech Arena

Investors eyeing opportunities in the biotechnology sector should take a closer look at Oculis Holding AG (OCS), a Switzerland-based clinical-stage biopharmaceutical company. With a remarkable analyst..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a Potential 95% Upside in the Biotech Sector

Investors with a keen interest in biotechnology may find Maze Therapeutics, Inc. (NASDAQ: MAZE) an intriguing prospect. With a market capitalization of $1.77 billion, Maze Therapeutics..

Altimmune, Inc. (ALT) Stock Analysis: Exploring the Potential 699.58% Upside

Altimmune, Inc. (NASDAQ: ALT), a promising player in the biotechnology sector, is capturing investor attention with its ambitious focus on novel therapies for serious liver diseases...

Taysha Gene Therapies (TSHA) Stock Report: Exploring the 208% Upside Potential

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing the attention of investors with its ambitious focus on developing adeno-associated virus-based gene therapies for severe monogenic diseases..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech Gem with 143% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector, particularly for investors seeking high-growth opportunities within the healthcare industry. With a market capitalization..

Auna SA (AUNA) Stock Analysis: Healthcare Giant’s 45% Potential Upside Beckons Investors

Auna SA (AUNA), a significant player in the healthcare sector, has attracted investor attention with a potential upside of 45.54%. Operating hospitals and clinics across Mexico,..

Kura Oncology, Inc. (KURA) Stock Analysis: Uncovering a 201% Upside in the Biotech Landscape

Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotechnology sector, is catching the eye of investors with a potential upside of over 201%. Situated..

Search

Funds

October 30, 2026

Search

Funds

October 30, 2026

FTSE 100

Funds